How RFK, Jr.’s False Vaccine Claims Are Holding up $600 Million to Fight Diseases in Poor Countries

Key Takeaways

• Kennedy blocks $600M vaccine funding for Gavi.
• He claims U.S. shots contain outdated, unsafe ingredients.
• Gavi’s vaccines are designed for low‑resource settings.
• Advocates warn funding hold could cost lives.
• Federal judge stopped Kennedy’s U.S. schedule overhaul.

Pulse Analysis

Gavi, the Global Alliance for Vaccines and Immunisation, channels U.S. and donor money to deliver lifesaving shots against measles, polio, malaria and nine other diseases in more than 50 low‑income countries. In the 2024‑25 fiscal year Congress allocated roughly $600 million for these programs, a sum that the State Department oversees as part of America’s health‑security agenda. The funding supports vaccines that are heat‑stable, require fewer doses and can be administered in remote clinics where cold‑chain infrastructure is unreliable. The partnership also leverages Gavi’s procurement power to negotiate lower prices, stretching each dollar further.

Robert F. Kennedy Jr., a prominent anti‑vaccine activist, has leveraged a pending lawsuit to withhold the disbursement, arguing that the products contain ingredients—such as thimerosal—that the United States has phased out. Although a federal judge recently blocked his attempt to rewrite the domestic immunisation schedule, Kennedy continues to pressure the State Department to replace Gavi’s formulations with those used in wealthier markets. Critics say his demands ignore the logistical realities of developing‑world immunisation and risk derailing a program that has prevented millions of deaths. His campaign cites thimerosal, a mercury‑based preservative, despite WHO’s endorsement of its safety in low‑dose formulations.

The pause threatens to create immunity gaps, especially in regions still battling measles and polio resurgences, and could reverse years of progress toward the World Health Organization’s 2030 vaccination targets. Beyond public‑health costs, the dispute signals how fringe political actors can disrupt U.S. soft‑power tools, eroding confidence among partner nations that American aid is reliable. Policymakers are urged to separate scientific evidence from ideology, expedite the release of the $600 million, and reinforce bipartisan oversight to safeguard global health security. If the funds remain frozen, donor confidence could wane, prompting other nations to reconsider their contributions to Gavi.